Long Term Use of Somatropin in Patients Small for Gestational Age

Pfizer

Status: Completed

Conditions: Small for Gestational Age

Treatments: Drug: Somatropin

Study type: Observational

Funder types: Industry

Identifiers

NCT00793325

A6281292

Details and patient eligibility

About

The objective of this surveillance is to collect information about 1) adverse drug reaction not expected from the LPD (unknown adverse drug reaction), 2) the incidence of adverse drug reactions in this surveillance, and 3)factors considered to affect the safety and/or efficacy of this drug.

Full description

All the patients whom an investigator prescribes the first Genotropin® should be registered consecutively until the number of subjects reaches target number in order to extract patients enrolled into the investigation at random.

Enrollment: 920 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients need to be administered Somatropin (Genotropin®) in order to be enrolled in the surveillance.

Exclusion criteria

• Patients not administered Somatropin (Genotropin®).

Trial design

920 participants in 1 patient group

Somatropin

Description:

Patients administered Somatropin.

Treatment:

Drug: Somatropin